BCWORLD PHARM (Korea) Performance
| 200780 Stock | KRW 4,800 10.00 0.21% |
The firm shows a Beta (market volatility) of -0.0524, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BCWORLD PHARM are expected to decrease at a much lower rate. During the bear market, BCWORLD PHARM is likely to outperform the market. At this point, BCWORLD PHARM has a negative expected return of -0.0783%. Please make sure to confirm BCWORLD PHARM's treynor ratio, value at risk, skewness, as well as the relationship between the maximum drawdown and potential upside , to decide if BCWORLD PHARM performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BCWORLD PHARM Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BCWORLD PHARM is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -18.8 B |
BCWORLD |
BCWORLD PHARM Relative Risk vs. Return Landscape
If you would invest 512,000 in BCWORLD PHARM Co on September 23, 2024 and sell it today you would lose (32,000) from holding BCWORLD PHARM Co or give up 6.25% of portfolio value over 90 days. BCWORLD PHARM Co is generating negative expected returns and assumes 2.2195% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than BCWORLD, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
BCWORLD PHARM Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BCWORLD PHARM's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BCWORLD PHARM Co, and traders can use it to determine the average amount a BCWORLD PHARM's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0353
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 200780 |
Estimated Market Risk
| 2.22 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BCWORLD PHARM is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BCWORLD PHARM by adding BCWORLD PHARM to a well-diversified portfolio.
BCWORLD PHARM Fundamentals Growth
BCWORLD Stock prices reflect investors' perceptions of the future prospects and financial health of BCWORLD PHARM, and BCWORLD PHARM fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BCWORLD Stock performance.
| Return On Equity | 0.35 | |||
| Return On Asset | 0.011 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 232.12 B | |||
| Shares Outstanding | 7.69 M | |||
| Price To Sales | 2.09 X | |||
| Revenue | 61.62 B | |||
| EBITDA | 8.08 B | |||
| Cash And Equivalents | 2.75 B | |||
| Total Debt | 43.82 B | |||
| Cash Flow From Operations | (5.08 M) | |||
| Total Asset | 185.1 B | |||
About BCWORLD PHARM Performance
By analyzing BCWORLD PHARM's fundamental ratios, stakeholders can gain valuable insights into BCWORLD PHARM's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BCWORLD PHARM has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BCWORLD PHARM has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about BCWORLD PHARM performance evaluation
Checking the ongoing alerts about BCWORLD PHARM for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BCWORLD PHARM help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BCWORLD PHARM generated a negative expected return over the last 90 days | |
| BCWORLD PHARM Co has accumulated about 2.75 B in cash with (5.08 M) of positive cash flow from operations. | |
| Roughly 39.0% of the company shares are owned by insiders or employees |
- Analyzing BCWORLD PHARM's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BCWORLD PHARM's stock is overvalued or undervalued compared to its peers.
- Examining BCWORLD PHARM's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BCWORLD PHARM's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BCWORLD PHARM's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BCWORLD PHARM's stock. These opinions can provide insight into BCWORLD PHARM's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BCWORLD Stock analysis
When running BCWORLD PHARM's price analysis, check to measure BCWORLD PHARM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BCWORLD PHARM is operating at the current time. Most of BCWORLD PHARM's value examination focuses on studying past and present price action to predict the probability of BCWORLD PHARM's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BCWORLD PHARM's price. Additionally, you may evaluate how the addition of BCWORLD PHARM to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |